PT - JOURNAL ARTICLE AU - Conte, Marc N. AU - Gordon, Matthew AU - Swartwood, Nicole A. AU - Wilwerding, Rachel AU - Yu, Chu A. (Alex) TI - The causal effects of chronic air pollution on the intensity of COVID-19 disease: Some answers are blowing in the wind AID - 10.1101/2021.04.28.21256146 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.28.21256146 4099 - http://medrxiv.org/content/early/2021/04/30/2021.04.28.21256146.short 4100 - http://medrxiv.org/content/early/2021/04/30/2021.04.28.21256146.full AB - The threats posed by COVID-19 have catalyzed a search by researchers across multiple disciplines for policy-relevant findings about critical risk factors. We contribute to this effort by providing causal estimates of the link between increased chronic ambient pollutant concentrations and the intensity of COVID-19 disease, as measured by deaths and hospitalizations in New York City from March through August, 2020. Given concerns about unobservable characteristics that contribute to both ambient air pollutant concentrations and the impacts of COVID-19 disease, we instrument for pollutant concentrations using the time spent downwind of nearby highways and estimate key causal relationships using two-stage least squares models. The causal links between increases in concentrations of our traffic-related air pollutants (PM2.5, NO2, and NO) and COVID-19 deaths are much larger than the correlations presented in recent observational studies. We find that a 0.16 μg/m3 increase in average ambient PM2.5 concentration leads to an approximate 30% increase in COVID-19 deaths. This is the change in concentration associated with being downwind of a nearby highway. We see that this effect is mostly driven by residents with at least 75 years of age. In addition to emphasizing the importance of searching for causal relationships, our analysis highlights the value of increasing the density of pollution-monitoring networks and suggests potential benefits of further tightening of Clean Air Act amendments, as our estimated effects occur at concentrations well below thresholds set by the National Ambient Air Quality Standards.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors have no external funding sources to declare.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Fordham University Institutional Review Board (FWA 00000067) waived the ethics approval for this research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPer a data-use agreement with the NYC DOHMH, we cannot share data on COVID-19 outcomes or testing.